Methylglyoxal Impairs Brain Microvascular Endothelial Cell Function In Vivo and In Vitro  by Tay, Aydin et al.
682a Wednesday, March 4, 2009to wildtype animals. Upon induction of hyperglycemia in knockouts, expression
of PKC d was only slightly increased to the level found in non-diabetic wild-
types. Expression, phosphorylation and translocation of PKC isoforms, how-
ever, remained unaffected by the induction of diabetes in Ga11-deficient mice.
We conclude that Ga11 is central to the induction of myocardial hypertrophy in
type 1 diabetes. Activation of PKC a and z appear to be important pathways in
hypertrophic signaling via Ga11. The inhibition of this pathway may in part
explain the strong therapeutic benefit of AT1 receptor blockade in diabetic pa-
tients.
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The responsiveness of cerebral microvasculature to stimulation by intrinsic li-
gands is altered during diabetes. Studies attribute this to a defect in endothelial
cell function. However, the etiology underlying endothelial cell dysfunction
during diabetes remains poorly characterized. Here we show that methyl-
glyoxal (MGO), a reactive carbonyl species whose production increases shortly
after the onset of hyperglycemia, impairs rat brain endothelial cell function, in
vivo and in vitro. When pial arterioles in anesthetized rats were exposed to
adenosine diphosphate (10mM) and nitroglycerin (1mM), vessel diameters in-
creased by 12.55 0.7% and 22.05 2.6%, respectively. Pre-treating arterioles
with 25mM of freshly synthesized MGO for 30 min at 370C, significantly atten-
uated the response of vessels to stimulation by adenosine diphosphate (4.65
1.1%), but the response to nitroglycerin was preserved (19.75 1.7%). In live-
cell confocal imaging employing relevant probes, acute exposure (15min) of rat
brain microvascular endothelial cells to MGO (25mM-100mM) triggered dose-
dependent increases in cytoplasmic and mitochondrial Ca2þ levels, and mito-
chondrial superoxide production. Acute exposure to MGO also reduced cyto-
plasmic nitric oxide level reminiscent of an increased cytoplasmic superoxide
production as well. Incubating rat brain microvascular endothelial cells with
MGO for 24hr at 370C MGO reduce cell viability in a dose-dependent manner
with an EC50 of 75mM. MGO treatment also reduced the viability of brain mi-
crovascular smooth muscle cells, but the EC50 was shifted rightwards to
300mM. Taken collectively, these data suggest that increased production of
MGO following early upregulation of semicarbazide-sensitive amine oxidase
(also referred to as vascular adhesion protein1) may be an initiating cause for
endothelial dysfunction during diabetes. (Work supported in part by grants
from NIH to WGM and KRB)
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Adenosine in the heart manifests an anti-adrenergic action that limits adrener-
gic stimulation of the myocardium. One mechanism involves the stimulation of
specific A1 receptors (A1R) that reduces b-adrenergic-induced Gs protein cy-
cling. This results in a reduction in adrenergic-enhanced adenylyl cyclase activ-
ity, cAMP levels, protein kinase A activation and contractile protein phosphor-
ylation. Adenosine via A1R has been reported by this laboratory to induce the
activation and translocation of PKCe to RACK2, and by others to induce phos-
phorylation and activation of p38-MAPKs. The latter exerts a negative inotro-
pic effect possibly by phosphorylating heat shock protein 27 (Hsp27), which
subsequently phosphorylates aB-crystallin resulting in a reduction in myofila-
ment Ca2þ sensitivity. The hypothesis of this study is that another mechanism
by which A1R limits contractile function involves the activation of a MAPK
cascade and the phosphorylation of Hsp27. Mouse hearts were isolated and per-
fused with physiological saline. After stabilization, agents were administered
for the designated times, whereupon hearts were freeze-clamped. Frozen heart
proteins were resolved by SDS-PAGE, transferred and blotted with antibodies
against Hsp27 and phospho-Hsp-27(Ser82). Stimulation of the heart with chlor-
ocyclopentyladenosine (CCPA, 1mM), an A1R agonist, for 5 min increased the
presence of phospho-Hsp27 by 2.6-fold, whereas treatment for 45 minutes in-
creased it by 27-fold. Furthermore, 45 min of CCPA increased the ratio of phos-
pho-Hsp27:total Hsp27 by 40-fold. Increases elicited by CCPA stimulation
were inhibited by the A1R antagonist DPCPX (0.1 mM) and by the p38-
MAPK inhibitor SB-203580 (2.64 mM). Together these data suggest that the
A1R modulates heart function by eliciting the phosphorylation of Hsp27 by
a signaling cascade involving p38-MAPK.3520-Pos Board B567
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In this study we investigated putative correlations between key proteins of the
Gq-coupled pathway and atrial arrhythmia (AA) in humans. For this purpose
we used quantitative real time PCR to investigate transcription levels of various
genes including: protein kinase C (PKC), phospholipase C and inositol-1,4,5-
trisphosphate receptor. The mRNA was isolated from human auricles obtained
from patients undergoing heart surgery that we divided into four groups:
1. patients with AA without cardio-specific medication
2. patients with AA receiving ACE- and/or beta-blocker
3. patients with sinus rhythm receiving ACE- and/or beta-blocker
4. patients with sinus rhythm without cardio-specific medication
Initial analysis of the mRNA appeared to suggest significant alterations of gene
transcription with respect to the groups (1-4). Gene transcripts that were up-reg-
ulated during disease were found to be down-regulated in patients receiving
cardio-specific medication. During atrial fibrillation structural remodeling oc-
curs. Thus we investigated whether such remodeling was also reflected in the
transcriptional activity of tissue specific marker genes. We found that e.g.
the transcriptional activity of the PKCa gene strongly correlated with markers
for endothelial cells and fibroblasts but did not show any correlation with my-
ocyte specific markers. This finding suggested that in human atria PKCa is not
expressed in the myocyte. Instead, transcriptional signals of this gene product
most likely solely originate from non-muscle cells. Results such as the one de-
scribed strongly suggest that qPCR analysis of entire cardiac tissue ought to be
interpreted in light of possible changes of the tissue composition that usually
accompanies cardiac diseases.
This work was supported by: German Science Foundation (DFG), SFB530 and
KliFor196
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Recent research demonstrates that membrane domains on the plasma mem-
brane of cells and the underlying cytoskeleton regulate subsequent receptor me-
diated signaling. However less is known about how the three dimensional
plasma membrane architecture created by proteins, lipids and cytoskeleton is
regulated by the cell itself. Influencing the architecture of the plasma membrane
by distinct signaling pathways may be one crucial mechanism for the cell to
selectively respond to external signaling stimuli. Therefore, signaling pathways
must be identified that affect its assembly.
Recently, we showed that membrane receptor and domain aggregation and their
dynamics drive bone stem cell differentiation toward osteoblastic lineage com-
mitment, however we failed to identify pathways necessary for lipid, protein
and cytoskeletal assembly. In order to identify these novel roles of classical
pathways, we employed the Family of Image Correlation Spectroscopy,
Atomic Force Microscopy followed by Fractal Analysis, roughness calcula-
tions, and molecular biology techniques to primary bone marrow stromal cells
isolated from mice; C57BL/6 (B6, control) and B6C3H-1-12 (1-12, high peak
bone density).
Our results revealed two signaling pathways that affect membrane morphology.
These signaling pathways are activated at distinct steps during osteoblast dif-
ferentiation and communication with surrounding cells. While triggering the
first signaling cascade altered the topography of the cell membrane by modify-
ing the maximum valley depth, the second pathway caused a change in the pe-
rimeter and area of distinct membrane regions. Our data suggest that osteoblast
precursor cells and osteoblasts undergo physical changes in the membrane de-
pendent on their stage of differentiation. These variations in the topography
were triggered by distinct signaling pathways causing a rearrangement of the
plasma membrane. These changes may be crucial for the response of the cells
to external stimuli received at various timeopoints during the differentiation
event.
3522-Pos Board B569
Specific Inhibition of Protein Kinase B Protects Against Ischemic Myocar-
dial Injury in Rat and Man
Jose` Linares-Palomino, Mohammad Ali Husainy, John Dickenson, Vien
Khach Lai, Nicholas Standen, Manuel Galin˜anes.
